During the past decade, University Physicians Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Physicians Group" #1 sponsor was "Shire" with 3 trials, followed by "Mannkind Corporation" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Cheryl Rosenfeld, DO" with 1 trials sponsored and "Gan and Lee Pharmaceuticals, USA" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Physicians Group" #1 collaborator was "Amylin Pharmaceuticals, LLC." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Integrated Medical Development" with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "University Physicians Group" are "Hypoparathyroidism" (4 trials), "Diabetes Mellitus, Type 1" (2 trials), "Type 2 Diabetes Mellitus" (2 trials), "Diabetes Type 2" (1 trials) and "Type 1 Diabetes" (1 trials). Many other conditions were trialed in "University Physicians Group" in a lesser frequency.

Most popular intervention types in "University Physicians Group" are "Drug" (7 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "NPSP558" (3 trials), "Placebo" (2 trials), "70% insulin aspart protamine suspension and 30% insulin aspart injection (rDNA origin)" (1 trials), "Comparator" (1 trials) and "Empagliflozin" (1 trials). Other intervention names were less common.

The vast majority of trials in "University Physicians Group" are 10 trials for "All" genders.

Currently, there are NaN active trials in "University Physicians Group". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in University Physicians Group, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University Physicians Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".